The Cooper Companies, Inc (COO) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.

Total Assets Chart for The Cooper Companies, Inc

The Cooper Companies, Inc (COO) total assets for FY2025 were USD 12.4B, a 0.6% change from FY2024. The Cooper Companies, Inc's total assets grew from USD 545.6M in 1985 to USD 12.4B in 2025 (2171.8% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 13.0%, 10-year CAGR of 10.8%, 20-year CAGR of 9.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$12.38B
Implied Share Price
$63.48
Enterprise Value
$14.79B
Revenue (TTM)
$4.23B
EBITDA
$886.40M
Profit Margin
5.57%
Trailing P/E
57.19
Forward P/E
13.79
Price/Book (MRQ)
1.60
Price/Sales (TTM)
2.93
EV/EBITDA
17.44
EV/Revenue
3.67
Dividend Yield
—
Book Value
$42.27
Free Cash Flow (FY2025)
$433.70M
Free Cash Flow Yield
3.50%

Snapshot as of 10th September 2026 — not point-in-time controlled, may lag the live market by a few days.